CNS Pharmaceuticals, Inc.
CNSP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001729427
In the last 90 days, CNS Pharmaceuticals, Inc. insiders filed 1 open-market purchase and 0 sales; 11 institutions reported holding it in 13F filings for Q2 2026, worth $1.34M in total; no superinvestor holds it.
Q1 2023 vs. Q4 2022
How the institutions holding CNS Pharmaceuticals, Inc. changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Q1 2023 | Change |
|---|---|---|---|
| Holders | 10 | 13 | +3 |
| Shares | 139.4K | 190.0K | +50.7K (+36.4%) |
| Value | $335.0K | $190.5K | −$144.5K (−43.1%) |
New holders (4)
Institutions that held CNS Pharmaceuticals, Inc. at the end of Q1 2023 but not at the end of Q4 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Renaissance Technologies LLC | 26,800 | $27.0K | 0.00% |
| Citadel Advisors LLC | 13,196 | $13.2K | 0.00% |
| Virtu Financial LLC | 11,119 | $11.0K | 0.00% |
| FMR LLC | 200 | $200 | 0.00% |
Sold out (1)
Institutions that held CNS Pharmaceuticals, Inc. at the end of Q4 2022 and filed for Q1 2023 without it.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| The PNC Financial Services Group, Inc. | 8 | $20 |